Diagnos Laboratorium (Indonesia) Analysis
| DGNS Stock | IDR 220.00 4.00 1.79% |
Diagnos Laboratorium Utama is overvalued with Real Value of 208.32 and Hype Value of 220.0. The main objective of Diagnos Laboratorium stock analysis is to determine its intrinsic value, which is an estimate of what Diagnos Laboratorium Utama is worth, separate from its market price. There are two main types of Diagnos Laboratorium's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Diagnos Laboratorium's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Diagnos Laboratorium's stock to identify patterns and trends that may indicate its future price movements.
The Diagnos Laboratorium stock is traded in Indonesia on Jakarta Exchange, with the market opening at 09:00:00 and closing at 15:50:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Indonesia.
Diagnos |
Diagnos Stock Analysis Notes
About 80.0% of the company shares are held by company insiders. The company recorded earning per share (EPS) of 51.84. Diagnos Laboratorium last dividend was issued on the 6th of August 2021. PT Diagnos Laboratorium Utama Tbk provides health services using laboratories. The company was founded in 2007 and is headquartered in Jakarta Pusat, Indonesia. Diagnos Laboratorium operates under Diagnostics Research classification in Indonesia and is traded on Jakarta Stock Exchange. It employs 406 people. To learn more about Diagnos Laboratorium Utama call the company at 62 21 3193 1833 or check out https://diagnos.co.id.Diagnos Laboratorium Investment Alerts
| Diagnos Laboratorium generated a negative expected return over the last 90 days | |
| Diagnos Laboratorium has high historical volatility and very poor performance | |
| About 80.0% of the company shares are held by company insiders |
Diagnos Market Capitalization
The company currently falls under 'Mega-Cap' category with a current market capitalization of 302.5 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Diagnos Laboratorium's market, we take the total number of its shares issued and multiply it by Diagnos Laboratorium's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Diagnos Profitablity
Diagnos Laboratorium's profitability indicators refer to fundamental financial ratios that showcase Diagnos Laboratorium's ability to generate income relative to its revenue or operating costs. If, let's say, Diagnos Laboratorium is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Diagnos Laboratorium's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Diagnos Laboratorium's profitability requires more research than a typical breakdown of Diagnos Laboratorium's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.06 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.06 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.06. Technical Drivers
As of the 30th of November, Diagnos Laboratorium shows the Mean Deviation of 2.35, standard deviation of 3.47, and Coefficient Of Variation of (790.51). Diagnos Laboratorium technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.Diagnos Laboratorium Price Movement Analysis
The output start index for this execution was nine with a total number of output elements of fifty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Diagnos Laboratorium middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Diagnos Laboratorium. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Diagnos Laboratorium Outstanding Bonds
Diagnos Laboratorium issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Diagnos Laboratorium uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Diagnos bonds can be classified according to their maturity, which is the date when Diagnos Laboratorium Utama has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| International Game Technology Corp BondUS460599AD57 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View |
Diagnos Laboratorium Predictive Daily Indicators
Diagnos Laboratorium intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Diagnos Laboratorium stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Diagnos Laboratorium Forecast Models
Diagnos Laboratorium's time-series forecasting models are one of many Diagnos Laboratorium's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Diagnos Laboratorium's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Diagnos Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Diagnos Laboratorium prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Diagnos shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Diagnos Laboratorium. By using and applying Diagnos Stock analysis, traders can create a robust methodology for identifying Diagnos entry and exit points for their positions.
PT Diagnos Laboratorium Utama Tbk provides health services using laboratories. The company was founded in 2007 and is headquartered in Jakarta Pusat, Indonesia. Diagnos Laboratorium operates under Diagnostics Research classification in Indonesia and is traded on Jakarta Stock Exchange. It employs 406 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Diagnos Laboratorium to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Earnings Calls Now
Earnings CallsCheck upcoming earnings announcements updated hourly across public exchanges |
| All Next | Launch Module |
Other Information on Investing in Diagnos Stock
Diagnos Laboratorium financial ratios help investors to determine whether Diagnos Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Diagnos with respect to the benefits of owning Diagnos Laboratorium security.